Kathleen Lang

Summary

Affiliation: Boston Health Economics
Country: USA

Publications

  1. ncbi Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, USA
    BMC Cancer 9:227. 2009
  2. ncbi Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA, USA
    BMC Health Serv Res 9:227. 2009
  3. ncbi Trends in the treatment of acute myeloid leukaemia in the elderly
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Drugs Aging 22:943-55. 2005
  4. ncbi Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Clin Gastroenterol Hepatol 7:198-204. 2009
  5. ncbi Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Arch Otolaryngol Head Neck Surg 135:582-8. 2009
  6. ncbi Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA, USA
    J Med Econ 14:217-26. 2011
  7. ncbi Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: a population-based analysis
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, Massachusetts, USA
    Drugs Aging 21:737-46. 2004
  8. ncbi The outcomes and costs of acute myeloid leukemia among the elderly
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
    Arch Intern Med 162:1597-603. 2002
  9. ncbi The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data
    Kathleen Lang
    Boston Health Economics Inc, Waltham, Mass, USA
    Arch Otolaryngol Head Neck Surg 130:1269-75. 2004
  10. ncbi Development of an interactive model of the burden of future coronary heart disease from an employer perspective
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    J Occup Environ Med 52:851-7. 2010

Collaborators

Detail Information

Publications12

  1. ncbi Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, USA
    BMC Cancer 9:227. 2009
    ..The purpose of this study was to estimate the relative impact of changes in demographics, stage at detection, treatment mix, and medical technology on 5-year survival among older colorectal cancer (CRC) patients...
  2. ncbi Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA, USA
    BMC Health Serv Res 9:227. 2009
    ..This retrospective cohort study evaluated healthcare resource use among US Medicare beneficiaries diagnosed with CRC between 1992 and 2002...
  3. ncbi Trends in the treatment of acute myeloid leukaemia in the elderly
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Drugs Aging 22:943-55. 2005
    ..Our findings can be used as a baseline against which the benefits of new therapies can be compared...
  4. ncbi Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Clin Gastroenterol Hepatol 7:198-204. 2009
    ..This study provides detailed estimates of lifetime and phase-specific colorectal cancer (CRC) treatment costs...
  5. ncbi Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Arch Otolaryngol Head Neck Surg 135:582-8. 2009
    ..To evaluate the incidence and costs of complications due to radiotherapy alone vs platinum-based chemoradiotherapy among patients diagnosed as having advanced squamous cell carcinoma of the head and neck (ASCCHN) from a payer perspective...
  6. ncbi Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA, USA
    J Med Econ 14:217-26. 2011
    ..To assess rates and predictors of medication nonadherence and hospitalization among patients with bipolar I disorder...
  7. ncbi Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: a population-based analysis
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, Massachusetts, USA
    Drugs Aging 21:737-46. 2004
    ..To fill this void, our study uses population-based data to evaluate longer-term treatment patterns, outcomes and costs among elderly Medicare beneficiaries following their diagnosis of CML...
  8. ncbi The outcomes and costs of acute myeloid leukemia among the elderly
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
    Arch Intern Med 162:1597-603. 2002
    ..The incidence of acute myeloid leukemia (AML) among the elderly can be expected to grow as the population continues to age. However, data on current treatment practices and costs for this form of cancer are sparse...
  9. ncbi The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data
    Kathleen Lang
    Boston Health Economics Inc, Waltham, Mass, USA
    Arch Otolaryngol Head Neck Surg 130:1269-75. 2004
    ..CONCLUSION: These results suggest that the health economic burden of SCCHN is substantial, with costs that are comparable with or higher than those of other solid tumors...
  10. ncbi Development of an interactive model of the burden of future coronary heart disease from an employer perspective
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    J Occup Environ Med 52:851-7. 2010
    ..To create a computer-based model for employers to better understand the burden of coronary heart disease (CHD) to their organizations...
  11. ncbi Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics
    Kathleen Lang
    Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
    Psychiatr Serv 61:1239-47. 2010
    ..This analysis assessed rates of medication adherence and predictors of nonadherence and hospitalization among patients treated with long-acting injectable and oral antipsychotic therapies...
  12. ncbi Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia
    Kathleen Lang
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Am J Health Syst Pharm 59:941-8. 2002
    ..Gemtuzumab ozogamicin appeared to be associated with equivalent survival and fewer total days of hospitalization than conventional chemotherapy in adults with relapsed AML...